Moderna’s mRNA flu shot earns FDA approval after rollercoaster review
Beth Mole • August 6, 2026 Despite significant drama from Trump officials this year, the Food and Drug Administration has for the first time approved a flu vaccine that uses mRNA technology. On Thursday, vaccine maker Moderna announced that its flu shot, mRNA-1010, aka mFLUSIVA, had earned approval for use in all adults ages 50